September 8, 2015 / 11:16 AM / in 2 years

Concordia Healthcare to buy Amdipharm Mercury for $3.5 bln

Sept 8 (Reuters) - Concordia Healthcare Corp said it would buy Amdipharm Mercury Ltd from private equity firm Cinven in a deal valued at $3.5 billion.

The deal gives Concordia a portfolio of more than 190 niche pharmaceutical products. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below